Ensemble, améliorons la qualité en santé

Transparency committee opinion

ATARAX

Date 09 May 2007
Pharmaceutical
formulation

2 mg/ml, syrup Fl/200 ml 25 mg, scored tablet B/30

ATC code
  1. N05BB01
Active ingredient

Hydroxyzine

Laboratory / Manufacturer UCB PHARMA
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication: “In children over 3 years second-line treatment of sleep-onset insomnia caused by a state of hyper-arousal (increased alertness due to anxiety at bedtime), after failure of behavioural measures alone.”

Documents

Contacts

Contact évaluation des médicaments